Oberwil, Switzerland

Allessandro Strebel

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Allessandro Strebel. Retrieved from https://idiyas.com/inventor/allessandro-strebel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Allessandro Strebel: Innovator in Pharmaceutical Chemistry

Introduction

Allessandro Strebel is a notable inventor based in Oberwil, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating neoplastic and autoimmune diseases.

Latest Patents

Strebel holds a patent for sulfopyrroles, which relates to compounds of a specific formula. These compounds are characterized by various aryl and heteroaryl groups. The patent details methods of synthesis for these compounds, as well as their use in pharmaceutical compositions aimed at treating neoplastic and autoimmune diseases.

Career Highlights

Strebel is associated with Takeda Pharmaceutical Company Limited, where he applies his expertise in pharmaceutical research and development. His work focuses on innovative solutions for complex medical conditions, contributing to advancements in treatment options.

Collaborations

Strebel has collaborated with notable colleagues, including Martin Eberle and Philipp Ermert. These partnerships enhance the research and development efforts within the pharmaceutical sector.

Conclusion

Allessandro Strebel's contributions to pharmaceutical chemistry and his innovative patent work exemplify his commitment to advancing medical treatments. His ongoing efforts continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…